A major milestone for the London Project to Cure Blindness
Successful trials of new treatment at Moorfields in fight against sight loss caused by AMD.
Patients regain sight after being first to receive retinal tissue engineered from stem cells:
- Successful trial on patients using new stem cell based treatment for wet age-related macular degeneration (AMD).
- Results from a clinical study suggest the treatment is safe and effective.
- The study is a major milestone for the London Project to Cure Blindness and could lead to an â€˜off-the-shelfâ€™ treatment within five years.
The first patients to receive a new treatment derived from stem cells for people with wet age-related macular degeneration (AMD) have regained reading vision.
The results of this ground-breaking clinical study, published in Nature Biotech, described the implantation of a specially engineered patch of retinal pigment epithelium cells derived from stem cells to treat people with sudden severe sight loss from wet AMD. It is hoped that it will also help treat dry AMD in the future.
Itâ€™s the first description of a complete engineered tissue that has been successfully used in this way.